BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36980230)

  • 1. Persistent CD8 T Cell Marks Caused by the HCMV Infection in Seropositive Adults: Prevalence of HLA-E-Reactive CD8 T Cells.
    Rousselière A; Charreau B
    Cells; 2023 Mar; 12(6):. PubMed ID: 36980230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HCMV triggers frequent and persistent UL40-specific unconventional HLA-E-restricted CD8 T-cell responses with potential autologous and allogeneic peptide recognition.
    Jouand N; Bressollette-Bodin C; Gérard N; Giral M; Guérif P; Rodallec A; Oger R; Parrot T; Allard M; Cesbron-Gautier A; Gervois N; Charreau B
    PLoS Pathog; 2018 Apr; 14(4):e1007041. PubMed ID: 29709038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinctive phenotype for HLA-E- versus HLA-A2-restricted memory CD8 αβT cells in the course of HCMV infection discloses features shared with NKG2C
    Rousselière A; Gérard N; Delbos L; Guérif P; Giral M; Bressollette-Bodin C; Charreau B
    Front Immunol; 2022; 13():1063690. PubMed ID: 36532017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ex vivo stimulation and expansion of both CD4(+) and CD8(+) T cells from peripheral blood mononuclear cells of human cytomegalovirus-seropositive blood donors by using a soluble recombinant chimeric protein, IE1-pp65.
    Vaz-Santiago J; Lulé J; Rohrlich P; Jacquier C; Gibert N; Le Roy E; Betbeder D; Davignon JL; Davrinche C
    J Virol; 2001 Sep; 75(17):7840-7. PubMed ID: 11483727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL.
    Wills MR; Carmichael AJ; Mynard K; Jin X; Weekes MP; Plachter B; Sissons JG
    J Virol; 1996 Nov; 70(11):7569-79. PubMed ID: 8892876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in HCMV immune cell frequency and phenotype are associated with chronic lung allograft dysfunction.
    Rousselière A; Delbos L; Foureau A; Reynaud-Gaubert M; Roux A; Demant X; Le Pavec J; Kessler R; Mornex JF; Messika J; Falque L; Le Borgne A; Boussaud V; Tissot A; Hombourger S; Bressollette-Bodin C; Charreau B
    Front Immunol; 2023; 14():1143875. PubMed ID: 37187736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a conserved HLA-A2-restricted decapeptide from the IE1 protein (pUL123) of human cytomegalovirus.
    Frankenberg N; Pepperl-Klindworth S; Meyer RG; Plachter B
    Virology; 2002 Apr; 295(2):208-16. PubMed ID: 12033779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping and Characterization of HCMV-Specific Unconventional HLA-E-Restricted CD8 T Cell Populations and Associated NK and T Cell Responses Using HLA/Peptide Tetramers and Spectral Flow Cytometry.
    Rousselière A; Delbos L; Bressollette C; Berthaume M; Charreau B
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human cytomegalovirus proteins pp65 and immediate early protein 1 are common targets for CD8+ T cell responses in children with congenital or postnatal human cytomegalovirus infection.
    Gibson L; Piccinini G; Lilleri D; Revello MG; Wang Z; Markel S; Diamond DJ; Luzuriaga K
    J Immunol; 2004 Feb; 172(4):2256-64. PubMed ID: 14764694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extent of Cytomegalovirus Replication in the Human Host Depends on Variations of the HLA-E/UL40 Axis.
    Vietzen H; Rückert T; Hartenberger S; Honsig C; Jaksch P; Geleff S; Hammer Q; Romagnani C; Segura-Wang M; Puchhammer-Stöckl E
    mBio; 2021 Mar; 12(2):. PubMed ID: 33727352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a lentiviral vector encoding a HCMV-chimeric IE1-pp65 protein for epitope identification in HLA-Transgenic mice and for ex vivo stimulation and expansion of CD8(+) cytotoxic T cells from human peripheral blood cells.
    Rohrlich PS; Cardinaud S; Lulè J; Montero-Julian FA; Prodhomme V; Firat H; Davignon JL; Perret E; Monseaux S; Necker A; Michelson S; Lemonnier FA; Charneau P; Davrinche C
    Hum Immunol; 2004 May; 65(5):514-22. PubMed ID: 15172452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of HLA-A*2402-restricted HCMV immediate early-1 (IE-1) epitopes as targets for CD8+ HCMV-specific cytotoxic T lymphocytes.
    Lim JB; Kim HO; Jeong SH; Ha JE; Jang S; Lee SG; Lee K; Stroncek D
    J Transl Med; 2009 Aug; 7():72. PubMed ID: 19698161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraocular human cytomegaloviruses of ocular diseases are distinct from those of viremia and are capable of escaping from innate and adaptive immunity by exploiting HLA-E-mediated peripheral and central tolerance.
    Shirane M; Yawata N; Motooka D; Shibata K; Khor SS; Omae Y; Kaburaki T; Yanai R; Mashimo H; Yamana S; Ito T; Hayashida A; Mori Y; Numata A; Murakami Y; Fujiwara K; Ohguro N; Hosogai M; Akiyama M; Hasegawa E; Paley M; Takeda A; Maenaka K; Akashi K; Yokoyama WM; Tokunaga K; Yawata M; Sonoda KH
    Front Immunol; 2022; 13():1008220. PubMed ID: 36341392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of HLA-A*0201-restricted T cell responses by natural polymorphism in the IE1(315-324) epitope of human cytomegalovirus.
    Prod'homme V; Retière C; Imbert-Marcille BM; Bonneville M; Hallet MM
    J Immunol; 2003 Feb; 170(4):2030-6. PubMed ID: 12574373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do variations in the HLA-E ligand encoded by UL40 distinguish individuals susceptible to HCMV disease?
    Waters S; Allcock RJN; Lee S; Downing J; Ariyanto I; Leary S; Munyard K; Irish A; Price P
    Hum Immunol; 2023 Feb; 84(2):75-79. PubMed ID: 36456304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and characterization of HLA-A*0201 tetramer loaded with IE-1316-324 antigenic peptide of human cytomegalovirus.
    Xu L; Zha Q; Sun H; Jia Q; Li F; He X
    Cell Mol Immunol; 2006 Oct; 3(5):367-71. PubMed ID: 17092434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes.
    Tan LC; Mowat AG; Fazou C; Rostron T; Roskell H; Dunbar PR; Tournay C; Romagné F; Peyrat MA; Houssaint E; Bonneville M; Rickinson AB; McMichael AJ; Callan MF
    Arthritis Res; 2000; 2(2):154-64. PubMed ID: 11062606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of human cytomegalovirus peptide-specific CD8(+) T-cell repertoire diversity following in vitro restimulation by antigen-pulsed dendritic cells.
    Peggs K; Verfuerth S; Pizzey A; Ainsworth J; Moss P; Mackinnon S
    Blood; 2002 Jan; 99(1):213-23. PubMed ID: 11756174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and HLA-tetramer-validation of human CD4+ and CD8+ T cell responses against HCMV proteins IE1 and IE2.
    Braendstrup P; Mortensen BK; Justesen S; Osterby T; Rasmussen M; Hansen AM; Christiansen CB; Hansen MB; Nielsen M; Vindeløv L; Buus S; Stryhn A
    PLoS One; 2014; 9(4):e94892. PubMed ID: 24760079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of CD8 T cell reactivity to cytomegalovirus using protein-spanning pools of overlapping pentadecapeptides.
    Kern F; Faulhaber N; Frömmel C; Khatamzas E; Prösch S; Schönemann C; Kretzschmar I; Volkmer-Engert R; Volk HD; Reinke P
    Eur J Immunol; 2000 Jun; 30(6):1676-82. PubMed ID: 10898504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.